GLP-1s linked to gallbladder risk in young people

A new study in JAMA Pediatrics found that obese adolescents and young adults taking GLP-1 receptor agonists had a higher risk of gallbladder and bile duct diseases. Researchers tracked outcomes for this group, showing a clear signal for a side effect already known in adults. This means clinicians will likely adjust how they screen young patients for these meds.